Naltrexone


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000855 Anorexia PMID:6120359
MESH:D003693 Delirium PMID:10506865
MESH:D003866 Depressive Disorder PMID:12851023
MESH:D003873 Dermatitis, Exfoliative PMID:7340503
MESH:D003875 Drug Eruptions PMID:7340503
MESH:D003967 Diarrhea PMID:15517116
MESH:D004244 Dizziness PMID:15517116; PMID:16534857; PMID:19453814
MESH:D004409 Dyskinesia, Drug-Induced PMID:14573388; PMID:15837582
MESH:D004890 Erythema PMID:7340503
MESH:D005076 Exanthema PMID:7340503
MESH:D005221 Fatigue PMID:15517116; PMID:17514344
MESH:D006212 Hallucinations PMID:7583704
MESH:D006261 Headache PMID:15517116; PMID:16195116; PMID:16534857; PMID:16978037; PMID:19453814; PMID:7583704; PMID:9400350
MESH:D006930 Hyperalgesia PMID:7464456
MESH:D006948 Hyperkinesis PMID:9078589
MESH:D007022 Hypotension PMID:2961881
MESH:D007319 Sleep Initiation and Maintenance Disorders PMID:16534857; PMID:19453963
MESH:D009021 Morphine Dependence PMID:10208762
MESH:D009325 Nausea PMID:15517116; PMID:16195116; PMID:16534857; PMID:16978037; PMID:17514344; PMID:19453814; PMID:9400350
MESH:D011297 Prenatal Exposure Delayed Effects PMID:9078589
MESH:D011537 Pruritus PMID:7340503
MESH:D011605 Psychoses, Substance-Induced PMID:10506865
MESH:D012640 Seizures PMID:15582832
MESH:D013375 Substance Withdrawal Syndrome PMID:10529020; PMID:11829123; PMID:12144610; PMID:1487626; PMID:1528400; PMID:15380837; PMID:15912139; PMID:16534857; PMID:17335644; PMID:19270623; PMID:4433085; PMID:56139; PMID:7340503; PMID:7675970
MESH:D014202 Tremor PMID:15912139
MESH:D014839 Vomiting PMID:15517116; PMID:16534857; PMID:19453814
MESH:D014987 Xerostomia PMID:16534857
MESH:D015431 Weight Loss PMID:15912139
MESH:D015746 Abdominal Pain PMID:16195116; PMID:16534857; PMID:999987
MESH:D016584 Panic Disorder PMID:9501763
MESH:D019970 Cocaine-Related Disorders PMID:17664051
MESH:D019973 Alcohol-Related Disorders PMID:17664051
MESH:D053609 Lethargy PMID:16534857
MESH:D056486 Chemical and Drug Induced Liver Injury PMID:24085192

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.